News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,967 Results
Type
Article (40923)
Company Profile (267)
Press Release (680767)
Multimedia
Podcasts (81)
Webinars (17)
Section
Business (204673)
Career Advice (2024)
Deals (35533)
Drug Delivery (110)
Drug Development (81384)
Employer Resources (173)
FDA (16414)
Job Trends (14945)
News (346398)
Policy (32728)
Tag
2027 Biotech Bay Standard (2)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2568)
Accelerated approval (33)
Adcomms (24)
Allergies (142)
Alliances (49575)
ALS (170)
Alzheimer's disease (1670)
Antibody-drug conjugate (ADC) (313)
Approvals (16686)
Artificial intelligence (515)
Autoimmune disease (159)
Automation (41)
Bankruptcy (361)
Best Places to Work (11636)
BIOSECURE Act (20)
Biosimilars (191)
Biotechnology (174)
Bladder cancer (157)
Brain cancer (57)
Breast cancer (640)
Cancer (4825)
Cardiovascular disease (400)
Career advice (1709)
Career pathing (36)
CAR-T (282)
CDC (44)
Celiac Disease (2)
Cell therapy (745)
Cervical cancer (36)
Clinical research (69592)
Collaboration (1708)
Company closure (4)
Compensation (1165)
Complete response letters (56)
COVID-19 (2713)
CRISPR (92)
C-suite (853)
Cystic fibrosis (143)
Data (6256)
Decentralized trials (2)
Denatured (25)
Depression (134)
Diabetes (502)
Diagnostics (6697)
Digital health (49)
Diversity (12)
Diversity, equity & inclusion (45)
Drug discovery (254)
Drug pricing (184)
Drug shortages (28)
Duchenne muscular dystrophy (233)
Earnings (90222)
Editorial (57)
Employer branding (21)
Employer resources (152)
Events (117333)
Executive appointments (978)
FDA (19547)
Fibrodysplasia Ossificans Progressiva (6)
Friedreich's ataxia (11)
Frontotemporal dementia (23)
Funding (1473)
Gene editing (198)
Generative AI (43)
Gene therapy (597)
GLP-1 (966)
Government (4660)
Grass and pollen (6)
Guidances (384)
Healthcare (18876)
HIV (60)
Huntington's disease (45)
IgA nephropathy (83)
Immunology and inflammation (253)
Immuno-oncology (57)
Indications (114)
Infectious disease (2986)
Inflammatory bowel disease (191)
Inflation Reduction Act (14)
Influenza (118)
Intellectual property (252)
Interviews (315)
IPO (16643)
IRA (50)
Job creations (3642)
Job search strategy (1428)
JPM (57)
Kidney cancer (16)
Labor market (86)
Layoffs (547)
Leadership (32)
Legal (7951)
Liver cancer (91)
Longevity (14)
Lung cancer (652)
Lymphoma (379)
Machine learning (42)
Management (59)
Manufacturing (799)
MASH (164)
Medical device (13773)
Medtech (13827)
Mergers & acquisitions (19964)
Metabolic disorders (1271)
Multiple sclerosis (163)
NASH (16)
Neurodegenerative disease (319)
Neuropsychiatric disorders (88)
Neuroscience (2906)
Neurotech (1)
NextGen: Class of 2026 (6519)
Non-profit (4515)
Now hiring (67)
Obesity (597)
Opinion (261)
Ovarian cancer (166)
Pain (198)
Pancreatic cancer (227)
Parkinson's disease (280)
Partnered (33)
Patents (501)
Patient recruitment (494)
Peanut (56)
People (58885)
Pharmaceutical (62)
Pharmacy benefit managers (29)
Phase 1 (21692)
Phase 2 (30627)
Phase 3 (22819)
Pipeline (5367)
Policy (283)
Postmarket research (2564)
Preclinical (9199)
Press Release (64)
Prostate cancer (238)
Psychedelics (48)
Radiopharmaceuticals (282)
Rare diseases (840)
Real estate (5954)
Recruiting (70)
Regulatory (24515)
Reports (53)
Research institute (2389)
Resumes & cover letters (352)
Rett syndrome (27)
RNA editing (16)
RSV (78)
Schizophrenia (148)
Series A (240)
Series B (190)
Service/supplier (11)
Sickle cell disease (97)
Special edition (22)
Spinal muscular atrophy (157)
Sponsored (42)
Startups (3615)
State (2)
Stomach cancer (17)
Supply chain (105)
Tariffs (84)
The Weekly (54)
Vaccines (1010)
Venture capital (89)
Weight loss (381)
Women's health (92)
Worklife (18)
Date
Today (122)
Last 7 days (535)
Last 30 days (2211)
Last 365 days (29906)
2026 (3696)
2025 (30172)
2024 (35215)
2023 (40075)
2022 (51174)
2021 (55710)
2020 (54083)
2019 (46538)
2018 (35018)
2017 (32108)
2016 (31480)
2015 (37553)
2014 (31318)
2013 (26345)
2012 (28570)
2011 (29263)
2010 (27328)
Location
Africa (736)
Alabama (83)
Alaska (7)
Arizona (309)
Arkansas (13)
Asia (39229)
Australia (6411)
California (11332)
Canada (3301)
China (1101)
Colorado (479)
Connecticut (479)
Delaware (339)
Europe (84564)
Florida (1700)
Georgia (357)
Hawaii (3)
Idaho (61)
Illinois (865)
India (67)
Indiana (524)
Iowa (22)
Japan (432)
Kansas (127)
Kentucky (39)
Louisiana (26)
Maine (72)
Maryland (1384)
Massachusetts (8110)
Michigan (326)
Minnesota (630)
Mississippi (5)
Missouri (128)
Montana (32)
Nebraska (28)
Nevada (122)
New Hampshire (78)
New Jersey (3013)
New Mexico (28)
New York (2987)
North Carolina (1460)
North Dakota (8)
Northern California (5541)
Ohio (334)
Oklahoma (21)
Oregon (41)
Pennsylvania (2287)
Puerto Rico (24)
Rhode Island (48)
South America (1108)
South Carolina (66)
South Dakota (1)
Southern California (4412)
Tennessee (176)
Texas (1748)
United States (40171)
Utah (337)
Vermont (1)
Virginia (263)
Washington D.C. (81)
Washington State (923)
West Virginia (4)
Wisconsin (109)
Wyoming (2)
721,967 Results for "duchesnay inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Driven by a common vision, Mochida Pharmaceutical Co., Ltd. and Duchesnay Inc. sign a partnership to help address the issue of drug gap in Japan
December 15, 2025
·
3 min read
Press Releases
Duchesnay Pharmaceutical Group implements a second shift to expand its production capacity to meet growing global demand
September 17, 2025
·
4 min read
Press Releases
Duchesnay Pharmaceutical Group creates Advisory Board to help guide the Group’s growth and success
April 16, 2025
·
5 min read
Duchesnay Inc. is seeking Health Canada approval for a segesterone acetate/ethinyl estradiol contraceptive vaginal system, a new option for women
Duchesnay Inc., member of Duchesnay Pharmaceutical Group (DPG) one of the few anchor companies selected by the Government of Canada for its Global Hypergrowth Project, has recently filed a New Drug Submission (NDS) to Health Canada for its segesterone acetate / ethinyl estradiol slow-release vaginal system developed for contraception control.
November 30, 2023
·
5 min read
Press Releases
Duchesnay Pharmaceutical Group wins 2024 Life Sciences Innovation Award from ADRIQ, the Association for the Development of Research and Innovation of Quebec
November 22, 2024
·
5 min read
Press Releases
Duchesnay Pharmaceutical Group celebrates expansion of its treatment portfolio for nausea and vomiting of pregnancy to 40 countries around the world
October 10, 2024
·
3 min read
Press Releases
BioSyent to Acquire Oral Science Inc.
February 9, 2026
·
10 min read
Press Releases
Coherus Oncology, Inc. Announces Closing of Public Offering of Common Stock
February 18, 2026
·
5 min read
Press Releases
Axogen, Inc. to Participate in Multiple Upcoming March 2026 Investor Conferences
February 17, 2026
·
1 min read
Press Releases
BrightSpring Health Services, Inc. to Host Investor Day on March 17, 2026
February 18, 2026
·
1 min read
1 of 72,197
Next
